Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.77
+0.34 (5.29%)
At close: Oct 29, 2025, 4:00 PM EDT
6.77
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:00 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $170.82 million as of October 29, 2025. Its market cap has increased by 43.09% in one year.
Market Cap
170.82M
Enterprise Value
136.89M
1-Year Change
43.09%
Ranking
Category
Stock Price
$6.77
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $170.82M, an increase of 194.48%. That is a compound annual growth rate of 33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 163.69M | 56.60% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |